Anti-MTA3 antibody
5
(3 Reviews)
|
(6 Publications)
Rabbit Polyclonal MTA3 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human MTA3 aa 400-450.
View Alternative Names
KIAA1266, MTA3, Metastasis-associated protein MTA3
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA3 antibody (AB87275)
ab87275 at 1/250 dilution staining MTA3 in Human breast carcinoma by Immunohistochemistry Formalin-fixed, Paraffin-embedded tissue. Detection : DAB staining
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA3 antibody (AB87275)
ab87275 at 1/250 dilution staining MTA3 in Human seminoma by Immunohistochemistry Formalin-fixed, Paraffin-embedded tissue. Detection : DAB staining
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Activities involving gene expression regulation occur through interactions with other chromatin-associated molecules. MTA3 participates as a component of the NuRD complex which also includes Mi2 and HDAC1 that is critical in chromatin remodeling and transcriptional repression. Through MTA3's involvement the complex influences cell proliferation differentiation and epithelial-mesenchymal transition (EMT).
Pathways
MTA3 is particularly significant in the EMT pathway affecting cell migration and invasion capacities. It interacts with proteins such as TWIST and ZEB1 which are associated with EMT. Additionally MTA3 plays a role in the Notch signaling pathway where it helps in maintaining proper cell lineage differentiation by modulating transcription factors through deacetylation processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 24:5998-6007 PubMed32187849
2020
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 18:1533033819892258 PubMed31870221
2019
Applications
Unspecified application
Species
Unspecified reactive species
AIMS medical science 4:17-27 PubMed28959722
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:2916-2935 PubMed27935866
2016
HIC1 (hypermethylated in cancer
- SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).
Applications
WB
Species
Unspecified reactive species
Molecular and cellular biology 36:1881-98 PubMed27161321
2016
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 30:745-50 PubMed23732279
2013
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com